Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.23841 http://scihub22266oqcxt.onion/10.18632/oncotarget.23841 C5880611!5880611!29632651     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncotarget 2018 ; 9 (20): 15375-85 Nephropedia Template TP {{tp|p=29632651|t=2018. Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies |pdf=|usr=}}{{29632651}} gab.com Text Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=29632651 #FOAvip Renal transplantation is associated with an increased risk of cancers at multiple sites; however, the relationships between increased cancer risk and participant characteristics remain unclear. We searched PubMed, Embase, and the Cochrane Library to identify prospective observational studies performed up to July 2017. Totally 11 prospective studies reported data on 79,988 renal transplant recipients were included. Renal transplant recipients were found to display a higher risk of all cancers (standard incidence ratio [SIR]: 2.89; 95% CI: 2.13?3.91; P < 0.001), gastric cancer (SIR: 1.93; 95% CI: 1.60?2.34; P < 0.001), colon cancer (SIR: 1.85; 95% CI: 1.53?2.23; P < 0.001), pancreatic cancer (SIR: 1.53; 95% CI: 1.23?1.91; P < 0.001), hepatocellular carcinoma (SIR: 2.45; 95% CI: 1.63?3.66; P < 0.001), lung cancer (SIR: 1.68; 95% CI: 1.29?2.19; P < 0.001), thyroid cancer (SIR: 5.04; 95% CI: 3.79?6.71; P < 0.001), urinary bladder cancer (SIR: 3.52; 95% CI: 1.48?8.37; P = 0.004), renal cell cancer (SIR: 10.77; 95% CI: 6.40?18.12; P < 0.001), non-melanoma skin cancer (SIR: 12.14; 95% CI: 6.37?23.13; P < 0.001), melanoma (SIR: 2.48; 95% CI: 1.08?5.67; P = 0.032), Hodgkin's lymphoma (SIR: 4.90; 95% CI: 3.09?7.78; P < 0.001), non-Hodgkin lymphoma (SIR: 10.66; 95% CI: 8.54?13.31; P < 0.001), lip cancer (SIR: 29.45; 95% CI: 17.85?48.59; P < 0.001), breast cancer (SIR: 1.11; 95% CI: 1.00?1.24; P = 0.046), and ovarian cancer (SIR: 1.60; 95% CI: 1.23?2.07; P < 0.001). However, renal transplantation did not significantly influence the risks of uterine cancer (P = 0.171), and prostate cancers (P = 0.188). Our findings suggest that patients who receive renal transplantation have an increased risk of cancer at most sites, apart from uterine and prostate cancers patients. Twit Text FOAVip Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=29632651 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29632651 #FOAvip English Wikipedia <ref>{{Cite pmid|29632651}}</ref> Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies #MMPMID29632651 Wang Y; Lan GB; Peng FH; Xie XB Oncotarget 2018[Mar]; 9 (20): 15375-85 PMID29632651show ga Renal transplantation is associated with an increased risk of cancers at multiple sites; however, the relationships between increased cancer risk and participant characteristics remain unclear. We searched PubMed, Embase, and the Cochrane Library to identify prospective observational studies performed up to July 2017. Totally 11 prospective studies reported data on 79,988 renal transplant recipients were included. Renal transplant recipients were found to display a higher risk of all cancers (standard incidence ratio [SIR]: 2.89; 95% CI: 2.13?3.91; P < 0.001), gastric cancer (SIR: 1.93; 95% CI: 1.60?2.34; P < 0.001), colon cancer (SIR: 1.85; 95% CI: 1.53?2.23; P < 0.001), pancreatic cancer (SIR: 1.53; 95% CI: 1.23?1.91; P < 0.001), hepatocellular carcinoma (SIR: 2.45; 95% CI: 1.63?3.66; P < 0.001), lung cancer (SIR: 1.68; 95% CI: 1.29?2.19; P < 0.001), thyroid cancer (SIR: 5.04; 95% CI: 3.79?6.71; P < 0.001), urinary bladder cancer (SIR: 3.52; 95% CI: 1.48?8.37; P = 0.004), renal cell cancer (SIR: 10.77; 95% CI: 6.40?18.12; P < 0.001), non-melanoma skin cancer (SIR: 12.14; 95% CI: 6.37?23.13; P < 0.001), melanoma (SIR: 2.48; 95% CI: 1.08?5.67; P = 0.032), Hodgkin's lymphoma (SIR: 4.90; 95% CI: 3.09?7.78; P < 0.001), non-Hodgkin lymphoma (SIR: 10.66; 95% CI: 8.54?13.31; P < 0.001), lip cancer (SIR: 29.45; 95% CI: 17.85?48.59; P < 0.001), breast cancer (SIR: 1.11; 95% CI: 1.00?1.24; P = 0.046), and ovarian cancer (SIR: 1.60; 95% CI: 1.23?2.07; P < 0.001). However, renal transplantation did not significantly influence the risks of uterine cancer (P = 0.171), and prostate cancers (P = 0.188). Our findings suggest that patients who receive renal transplantation have an increased risk of cancer at most sites, apart from uterine and prostate cancers patients. äCancer risks in recipients of renal transplants: a meta-analysis of co(epmc).pdf DeepDyve Pubget Overpricing